Integer Holdings CORP 10-Q quarterly reports

Integer Holdings Corporation's Q2 2026 results show a decline in sales and profitability, alongside significant restructuring charges and the announcement of a pending acquisition by KKR.

Integer Holdings Corporation reported a net income of $16.5 million for the first quarter of 2026, a significant improvement from a $22.5 million loss in the prior year, while initiating a strategic review to maximize shareholder value.

Integer Holdings Corporation filed an amended quarterly report to provide additional context on its sales outlook, noting lower than anticipated demand for certain emerging customer products and expected declines for three new products in 2026.

Integer Holdings Corporation announced increased sales and gross profit for Q3 and YTD 2025, driven by strategic acquisitions and demand, despite a significant one-time debt conversion expense impacting year-to-date net income.

Integer Holdings Corporation reported increased sales and gross profit for the second quarter and first six months of 2025, driven by strategic acquisitions and new product ramps, despite a significant one-time debt conversion expense impacting net income for the six-month period.

Integer Holdings Corporation's Q1 2025 results reflect increased sales offset by debt conversion expenses, acquisition costs, and a loss from continuing operations.

Integer Holdings Corporation reported a strong third quarter in 2024, with increased sales and profitability driven by its medical segment and recent acquisitions, while also announcing the divestiture of its non-medical segment.

Integer Holdings Corporation announced positive second quarter and first six months 2024 results, with revenue growth driven by its Medical segment and recent acquisitions.

Integer Holdings Corporation reported a strong first quarter in 2024, with increased sales and profitability driven by its Medical segment and recent acquisitions.